Pi Pharma Intelligence’s Contributions Extend Beyond the Pharmaceutical Industry to Include Academia
AchievementWe are glad to see Pi Pharma Intelligence rising as a trusted provider of data, Today marks our first contribution to an article published at the Annals of Pharmacotherapy on Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma with BRAF Mutation, we thank all the authors for their trust and special thanks to our advisor Dr.Nimer Alkhatib
Enhancing Leadership Capabilities Through Strategic Time Management Training
May, 2024
Enhancing Leadership Capabilities Through Strategic Time Management Training
Pi Pharma at the International Digital Cooperation Forum!
Feb, 2025
Pi Pharma joined the DCO's International Digital Cooperation Forum to discuss the challenges of scaling AI-driven health tech globally.
Pi Pharma Intelligence Joins GCC Regulatory Affairs Pharma Summit 2025 as Silver Sponsor
Jan, 2025
Pi Pharma Intelligence is a Silver Sponsor at the GCC Regulatory Affairs Pharma Summit 2025, offering key insights into drug patents, regulatory approvals, and clinical trials for smarter decisions.